[This Form 6-K consists of: 1. 2. 3. an announcement regarding receipt of the results compensation amount of the Regitrant; Document 1 THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred PROPOSAL ON ELECTION OF NEW SESSION OF THE BO]
[Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F Fourth Quarter and Full Year 2019 Financial Summary Ÿ Sales for the fourth quarter of 2019 were $81.1 million, an increase of 52.4% from $53.2 million in the prior year period. Ÿ Sales in 2019 w]
[For further information contact: Investor Relations Department Country/City Code 8862 Tel: 2656-8096 IR@gigamedia.com.tw GigaMedia Announces First-Quarter 2020 Financial Results TAIPEI, Taiwan, April 30, 2020 – GigaMedia Limited (NASDAQ: GIGM) today announced its first-quarter 2020 unaudited financi]
[This Form 6-K consists of: 1. 2. 3. an announcement regarding receipt of the results compensation amount of the Regitrant; Document 1 THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred PROPOSAL ON ELECTION OF NEW SESSION OF THE BO]
[Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F Fourth Quarter and Full Year 2019 Financial Summary Ÿ Sales for the fourth quarter of 2019 were $81.1 million, an increase of 52.4% from $53.2 million in the prior year period. Ÿ Sales in 2019 w]
[Golenbock Eiseman Assor Bell & Peskoe LLP th 711 Third Avenue, 17 New York, New York 10017 (212) 212-907-7300 April 30, 2020 Re: Origin Agritech Limited. Filed on April 16, 2020 Dear Ms. Paik and Mr. McCann: Registration Statement on Form F-1, Filed April 16, 2020 General 1. We note your Form 6-K fi]
[EX-10.1 2 ea121227ex10-1_sharing.htm CONSULTING, PUBLIC RELATIONSHIP AND MARKETING LETTER AGREEMENT DATED APRIL 21, 2020 BY AND BETWEEN SHARING ECONOMY INTERNATIONAL INC AND STOCKVEST] []
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[NONE (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 35,524,950 ordinary shares, par value US$0.00375 per share. ☐ Yes ☒ No ☐ Yes ☒ No ☒ Yes ☐ No . ☒ Yes ☐ No ☐ Large] [P]
[NONE (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 35,524,950 ordinary shares, par value US$0.00375 per share. ☐ Yes ☒ No ☐ Yes ☒ No ☒ Yes ☐ No . ☒ Yes ☐ No ☐ Large] [P]
